Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to Know
Hypertrophic cardiomyopathy (HCM) is the most common inherited monogenic cardiac disorder, affecting 0.2-0.5% of the population.
New Focus on Renin-Angiotensin System Role in COVID-19
Two new studies have been published that further focus attention on how the renin–angiotensin system — and specifically the ACE2 receptor — may be involved in COVID-19 infection.
Multiple Sclerosis Tied to Increased Risk for Stroke, CVD, Death
Multiple sclerosis (MS) is associated with an increased risk for acute coronary syndrome (ACS), stroke, and death, a finding that is unexplained by traditional risk factors, new research suggests.
Diastolic Dysfunction a Common Risk Factor for Cognitive Decline
Diastolic dysfunction, a common and often undiagnosed condition in older individuals, could be contributing to the increasing burden of cognitive decline, a new study suggests.
Exploring Postinfarction Reentrant Ventricular Tachycardia With Entrainment Mapping
Ventricular tachycardia late after myocardial infarction is usually due to reentry in the infarct region. These reentry circuits can be large, complex and difficult to define, impeding study in the electrophysiology laboratory and making catheter ablation difficult.
Appeals to “stay at home” during COVID-19 do not apply to heart attacks
People experiencing heart attacks should immediately phone the emergency services – even during the COVID-19 pandemic. The urgent call from the European Society of Cardiology (ESC) comes as hospitals in Europe and beyond report dramatic reductions in heart attack admissions.
Vitamin K Antagonists and Osteoporotic Fractures: Insights From Comparisons With the NOACs
Vitamin K antagonists (VKAs; warfarin mostly, but also acenocoumarol, phenprocoumon, phenindione, and fluindione) have been a cornerstone in medicine as the first and the only available oral anticoagulants (OACs) for clinical use for over half a century.
High haemoglobin A1c level is a possible risk factor for ventricular fibrillation in sudden cardiac arrest among non-diabetic individuals in the general population
This study aimed to establish whether higher levels of glycated haemoglobin (HbA1c) are associated with increased sudden cardiac arrest (SCA) risk in non-diabetic individuals.
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes (22%).
Mitral Regurgitation Management Focused Update: Key Points
This is an update to the 2017 American College of Cardiology (ACC) expert consensus decision pathway (ECDP) on the management of mitral regurgitation (MR).
FDA Approves First Pulsed Field Ablation System for AF
The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.
Eating An Egg A Day Is A-OK, Despite Heart Disease History, New Study Suggests
Interest in high-protein and high-fat diets like the keto diet keeps growing, but concerns about the health effects of many foods on those diets remain high. For at least one of those foods—the simple protein-packed egg—a new, large-scale study suggests that devouring one a day is fine for most people, even those with a history of heart disease.
Marijuana may cause the same cardiovascular damage as cigarettes
More than two million Americans with heart disease are using or have used marijuana - and it could put them at risk of dangerously heavy bleeding and other complications, a new study warns.
Don't Stop the Statin! Christopher P. Cannon
Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.
Expert point of view
Strategies to Overcome Residual Risk During Statins Era
PreHT 2020|Vilnius | Lithuania | 2-5 April 2020
7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)
FDA Clears Architect Stat High-Sensitivity Troponin Test for MI
The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.
World Heart Day 2019
This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.